Skip to main content
Top
Published in: Digestive Diseases and Sciences 10/2018

01-10-2018 | Editorial

Benign Biliary Strictures: Narrowing the Differences Between Endoscopic and Surgical Treatments

Authors: May Y. W. Wong, Arthur J. Kaffes

Published in: Digestive Diseases and Sciences | Issue 10/2018

Login to get access

Excerpt

Benign biliary strictures (BBS) affecting the common hepatic or bile ducts can be complicated by obstructive jaundice and infection. The majority of benign strictures are iatrogenic, secondary to bile duct injury after liver transplantation or laparoscopic cholecystectomy, with reported incidence ranging from 3 to 13% [1] and 0.2–0.7% [2, 3], respectively. They can also be inflammatory, infectious, or complicate diseases such as chronic pancreatitis. Research into preventative measures for patients who are at greater risk of developing BBS such as liver transplant recipients of reduced-size grafts or grafts subjected to prolonged cold ischemic time, or those with hepatic artery thrombosis or blood group ABO incompatibility [4, 5] is needed. …
Literature
1.
go back to reference Pascher A, Neuhaus P. Bile duct complications after liver transplantation. Transpl Int Off J Eur Soc Organ Transplant. 2005;18:627–642.CrossRef Pascher A, Neuhaus P. Bile duct complications after liver transplantation. Transpl Int Off J Eur Soc Organ Transplant. 2005;18:627–642.CrossRef
2.
go back to reference MacFadyen BV Jr, Vecchio R, Ricardo AE, Mathis CR. Bile duct injury after laparoscopic cholecystectomy. The United States experience. Surg Endosc. 1998;12:315–321.CrossRefPubMed MacFadyen BV Jr, Vecchio R, Ricardo AE, Mathis CR. Bile duct injury after laparoscopic cholecystectomy. The United States experience. Surg Endosc. 1998;12:315–321.CrossRefPubMed
3.
go back to reference Roslyn JJ, Binns GS, Hughes EF, Saunders-Kirkwood K, Zinner MJ, Cates JA. Open cholecystectomy. A contemporary analysis of 42,474 patients. Ann Surg. 1993;218:129–137.CrossRefPubMedPubMedCentral Roslyn JJ, Binns GS, Hughes EF, Saunders-Kirkwood K, Zinner MJ, Cates JA. Open cholecystectomy. A contemporary analysis of 42,474 patients. Ann Surg. 1993;218:129–137.CrossRefPubMedPubMedCentral
4.
go back to reference Moser MA, Wall WJ. Management of biliary problems after liver transplantation. Liver Transplant Off Publ Am Assoc Study Liver Dis Int Liver Transplant Soc. 2001;7:S46–52. Moser MA, Wall WJ. Management of biliary problems after liver transplantation. Liver Transplant Off Publ Am Assoc Study Liver Dis Int Liver Transplant Soc. 2001;7:S46–52.
5.
go back to reference Qian YB, Liu CL, Lo CM, Fan ST. Risk factors for biliary complications after liver transplantation. Arch Surg (Chicago, Ill: 1960). 2004;139:1101–1105. Qian YB, Liu CL, Lo CM, Fan ST. Risk factors for biliary complications after liver transplantation. Arch Surg (Chicago, Ill: 1960). 2004;139:1101–1105.
6.
go back to reference Hu B, Sun B, Cai Q, et al. Asia-Pacific consensus guidelines for endoscopic management of benign biliary strictures. Gastrointestinal Endosc. 2017;86:44–58.CrossRef Hu B, Sun B, Cai Q, et al. Asia-Pacific consensus guidelines for endoscopic management of benign biliary strictures. Gastrointestinal Endosc. 2017;86:44–58.CrossRef
7.
go back to reference Kaffes AJ. Management of benign biliary strictures: current status and perspective. J Hepato Biliary Pancreat Sci. 2015;22:657–663.CrossRef Kaffes AJ. Management of benign biliary strictures: current status and perspective. J Hepato Biliary Pancreat Sci. 2015;22:657–663.CrossRef
8.
go back to reference Huszar O, Kokas B, Matrai P, et al. Meta-analysis of the long term success rate of different interventions in benign biliary stricture. PloS one. 2017;12:e0169618.CrossRefPubMedPubMedCentral Huszar O, Kokas B, Matrai P, et al. Meta-analysis of the long term success rate of different interventions in benign biliary stricture. PloS one. 2017;12:e0169618.CrossRefPubMedPubMedCentral
10.
go back to reference James SK, Stenestrand U, Lindback J, et al. Long-term safety and efficacy of drug-eluting versus bare-metal stents in Sweden. New Engl J Med. 2009;360:1933–1945.CrossRefPubMed James SK, Stenestrand U, Lindback J, et al. Long-term safety and efficacy of drug-eluting versus bare-metal stents in Sweden. New Engl J Med. 2009;360:1933–1945.CrossRefPubMed
11.
go back to reference Shi J, Lv Y, Yu L, et al. Interest of a new biodegradable stent coated with paclitaxel on anastomotic wound healing after biliary reconstruction. Eur J Gastroenterol Hepatol. 2013;25:1415–1423.CrossRefPubMed Shi J, Lv Y, Yu L, et al. Interest of a new biodegradable stent coated with paclitaxel on anastomotic wound healing after biliary reconstruction. Eur J Gastroenterol Hepatol. 2013;25:1415–1423.CrossRefPubMed
12.
go back to reference Marubashi S, Dono K, Nagano H, et al. Biliary reconstruction in living donor liver transplantation: technical invention and risk factor analysis for anastomotic stricture. Transplantation. 2009;88:1123–1130.CrossRefPubMed Marubashi S, Dono K, Nagano H, et al. Biliary reconstruction in living donor liver transplantation: technical invention and risk factor analysis for anastomotic stricture. Transplantation. 2009;88:1123–1130.CrossRefPubMed
13.
go back to reference Tian YH, Xu Z, Zhang XQ, Shen W, Zhou XS, Dong JH. Development of an animal model for assessment of primary end-to-end biliary reconstruction. Eur Surg. 2012;44:177–183.CrossRef Tian YH, Xu Z, Zhang XQ, Shen W, Zhou XS, Dong JH. Development of an animal model for assessment of primary end-to-end biliary reconstruction. Eur Surg. 2012;44:177–183.CrossRef
Metadata
Title
Benign Biliary Strictures: Narrowing the Differences Between Endoscopic and Surgical Treatments
Authors
May Y. W. Wong
Arthur J. Kaffes
Publication date
01-10-2018
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 10/2018
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-018-5212-3

Other articles of this Issue 10/2018

Digestive Diseases and Sciences 10/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.